Alekseyev Yuriy O, Fazeli Roghayeh, Yang Shi, Basran Raveen, Maher Thomas, Miller Nancy S, Remick Daniel
Department of Pathology and Laboratory Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA.
Acad Pathol. 2018 May 6;5:2374289518766521. doi: 10.1177/2374289518766521. eCollection 2018 Jan-Dec.
Next-generation sequencing refers to a high-throughput technology that determines the nucleic acid sequences and identifies variants in a sample. The technology has been introduced into clinical laboratory testing and produces test results for precision medicine. Since next-generation sequencing is relatively new, graduate students, medical students, pathology residents, and other physicians may benefit from a primer to provide a foundation about basic next-generation sequencing methods and applications, as well as specific examples where it has had diagnostic and prognostic utility. Next-generation sequencing technology grew out of advances in multiple fields to produce a sophisticated laboratory test with tremendous potential. Next-generation sequencing may be used in the clinical setting to look for specific genetic alterations in patients with cancer, diagnose inherited conditions such as cystic fibrosis, and detect and profile microbial organisms. This primer will review DNA sequencing technology, the commercialization of next-generation sequencing, and clinical uses of next-generation sequencing. Specific applications where next-generation sequencing has demonstrated utility in oncology are provided.
下一代测序是指一种高通量技术,可确定样本中的核酸序列并识别变异。该技术已被引入临床实验室检测,并为精准医学提供检测结果。由于下一代测序相对较新,研究生、医学生、病理学住院医师和其他医生可能会从入门介绍中受益,该介绍可为基本的下一代测序方法和应用以及其具有诊断和预后效用的具体实例提供基础。下一代测序技术源于多个领域的进展,从而产生了具有巨大潜力的复杂实验室检测。下一代测序可用于临床环境,以寻找癌症患者的特定基因改变、诊断诸如囊性纤维化等遗传性疾病以及检测和分析微生物。本入门介绍将回顾DNA测序技术、下一代测序的商业化以及下一代测序的临床应用。还提供了下一代测序在肿瘤学中已证明有用的具体应用。